Abstract
In the Langendorff isolated perfused rat heart, 36% of total basal protein degradation was inhibited by the lysosomal inhibitor chloroquine (30 microM), after elimination of rapid turnover proteins during a 3 h preliminary degradation period. Prior inhibition of degradation with chloroquine was additive to the 30% inhibition caused by simultaneous infusion of 50-200 nM-isoprenaline. This additivity suggests that the adrenergic-controlled process is independent of the lysosomal degradative pathway. After discontinuation of drug infusions, the isoprenaline-inhibited degradation rate returned to the previous baseline; however, the chloroquine-inhibited degradation rate transiently exceeded the previous baseline. NaN3 (0.3 mM) caused a decrease of left-ventricular myocardial ATP content of approx. 60% at 14 min and extreme impairment of contractile function; however, the total lysosomal and non-lysosomal protein degradation was not changed at this time. Conversely, left-ventricular tissue ATP content was not changed during proteolytic inhibition by 10 nM-isoprenaline or 10 microM-chloroquine at 14 min. The results indicate that depletion of myocardial energy stores in this preparation is neither necessary nor sufficient to cause inhibition of the total of lysosomal and non-lysosomal protein degradation.
MeSH Terms
2,4-Dinitrophenol
Adenosine Triphosphate/metabolism
Animals
Azides/pharmacology
Chloroquine/pharmacology
Dinitrophenols/pharmacology
Heart/drug effects
Isoproterenol/pharmacology
Leucine/metabolism
Lysosomes/metabolism
Myocardium/metabolism
Perfusion
Proteins/metabolism
Rats
Sodium Azide
Chemicals
Azides
Dinitrophenols
Proteins
Chloroquine
Adenosine Triphosphate
Sodium Azide
Leucine
Isoproterenol
2,4-Dinitrophenol
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Lockwood T D
Department of Pharmacology and Toxicology, School of Medicine, Wright State University, Dayton, OH 45435.
References (15)
15 references, click to expand
-
Effect of medium composition on protein degradation and DNA synthesis in rat embryo fibroblasts.
Proc Natl Acad Sci U S A. 1977 Jun;74(6):2427-31
PMID: 267935
-
Intracellular calcium homeostasis.
Annu Rev Biochem. 1987;56:395-433
PMID: 3304139
-
Degradation of the acetylcholine receptor in cultured muscle cells: selective inhibitors and the fate of undegraded receptors.
Cell. 1980 Feb;19(2):481-91
PMID: 7357615
-
Inhibition of protein degradation in the energy-poor heart.
Adv Myocardiol. 1980;1:535-46
PMID: 6994187
-
Lethal myocardial ischemic injury.
Am J Pathol. 1981 Feb;102(2):241-55
PMID: 7008621
-
Mechanisms of intracellular protein breakdown.
Annu Rev Biochem. 1982;51:335-64
PMID: 6287917
-
Protein turnover and proliferation. Turnover kinetics associated with the elevation of 3T3-cell acid-proteinase activity and cessation of net protein gain.
Biochem J. 1982 Aug 15;206(2):239-49
PMID: 6756389
-
Effects of cardiac work and leucine on protein turnover.
Adv Myocardiol. 1983;4:115-25
PMID: 6856954
-
31P NMR spectroscopy of rat organs, in situ, using chronically implanted radiofrequency coils.
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7491-5
PMID: 6584867
-
Inositol trisphosphate and diacylglycerol as second messengers.
Biochem J. 1984 Jun 1;220(2):345-60
PMID: 6146314
-
The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts.
J Biol Chem. 1985 Mar 25;260(6):3344-9
PMID: 3972829
-
The effects of anoxia on cytosolic free calcium, calcium fluxes, and cellular ATP levels in cultured kidney cells.
J Biol Chem. 1985 Sep 25;260(21):11619-26
PMID: 3930481
-
Simultaneous response of myocardial contractility and a major proteolytic process to beta-adrenergic-receptor occupancy in the Langendorff isolated perfused rat heart.
Biochem J. 1985 Oct 15;231(2):299-308
PMID: 2998346
-
Toxic cardiomyopathy: the effect of antipsychotic-antidepressant drugs and calcium on myocardial protein degradation and structural integrity.
Toxicol Appl Pharmacol. 1986 Nov;86(2):308-24
PMID: 2878513
-
Ligands of cytochrome c oxidase.
Methods Enzymol. 1978;53:191-201
PMID: 213678